Charles Marks
Family Medicine · Chesapeake, VANPI 1184635518
Payments from drug & device makers
Across 271 payments — averaging $29.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Novo Nordisk$832
- Paratek Pharmaceuticals, Inc.$812
- Lilly USA, LLC$804
- Biohaven Pharmaceuticals, Inc.$401
- plus $3K from 20 others
What the payments were for
- Consulting fees$80010%
- Food & beverage$7,23090%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $1,345 |
| AstraZeneca | 30 | $1,063 |
| Novo Nordisk | 26 | $832 |
| Paratek Pharmaceuticals, Inc. | 2 | $812 |
| Lilly USA, LLC | 34 | $804 |
| Biohaven Pharmaceuticals, Inc. | 10 | $401 |
| Amarin Pharma, Inc. | 18 | $365 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $357 |
| Pfizer | 16 | $305 |
| Johnson & Johnson | 7 | $300 |
| Amgen | 4 | $277 |
| GSK | 8 | $231 |
| Daiichi Sankyo Inc. | 6 | $186 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $160 |
| Boehringer Ingelheim | 4 | $150 |
| Esperion Therapeutics, Inc. | 2 | $120 |
| Merck | 5 | $76 |
| Jazz Pharmaceuticals Inc. | 3 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| Zyla Life Sciences, Inc. | 3 | $35 |
| Dexcom, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Eisai Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,048 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 15 | $323 |
| Ondansetron OdtOndansetron | 12 | $312 |
| Metoprolol Succinate | 23 | $280 |
| Pantoprazole Sodium | 20 | $278 |
| Omeprazole | 12 | $271 |
| Tamsulosin Hcl | 15 | $249 |
| Losartan Potassium | 26 | $238 |
| Allopurinol | 13 | $227 |
| Levothyroxine Sodium | 25 | $226 |
| Rosuvastatin Calcium | 13 | $199 |
| Atorvastatin Calcium | 24 | $178 |
| Lisinopril | 23 | $152 |
| Simvastatin | 18 | $146 |
| Amlodipine Besylate | 34 | $140 |
| Metformin Hcl | 23 | $131 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chesapeake
- Samir AbdelshaheedChesapeake$642K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.